The rise in investments in R&D, support from government initiatives and increased fundings from private and public organizations for producing AI-enhanced diagnostic tools is strengthening the industries in the region.” Avant Technologies, Inc.(OTCQB: AVAI) and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit - Avant Technologies, Inc.("Avant” or the "Company”) and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that following Ainnova’s sponsorship and its CEO’s key role at the 2025 Healthcare Innovation Summit in Mexico City, both Avant and Ainnova, through their joint venture, Ai-nova Acquisition Corp.(AAC), are building on Ainnova’s strong presence in Mexico by expanding its footprint across Latin America.
The application of AI tools in diagnostics has led to analyzing medical images for assessing disease progression, predicting patient outcomes, processing and storing of patient data which includes electronic health records (EHRs), identifying patterns and anomalies in patient data and symptom checkers for providing potential diagnosis.” Active healthcare/tech companies active in the markets include: Avant Technologies Inc.(OTCQB: AVAI), Illumina Inc.(NASDAQ: ILMN), Tempus AI, Inc.(NASDAQ: TEM), Medtronic plc (NYSE: MDT), Spectral AI, Inc.(NASDAQ: MDAI).
Ainnova is currently addressing regulatory pathways in Brazil with the support of its MDSAP certification to meet ANVISA requirements, paving the way for rapid market entry. CONTINUED… Read this and more news for Avant Technologies at: In other developments and happenings in the markets recently include: Medtronic plc (NYSE: MDT), a global leader in healthcare technology, recently announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial.
The story "Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations" has 1980 words across 60 sentences, which will take approximately 9 - 17 minutes for the average person to read.
Which news outlet covered this story?
The story "Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations" was covered 1 weeks ago by GlobeNewswire, a news publisher based in China.
How trustworthy is 'GlobeNewswire' news outlet?
GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.
The outlet is headquartered in China and publishes an average of 93 news stories per day.
It's most recent story was published 8 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
